﻿<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
  <url>
    <loc>http://xeloda.legalview.com/news-articles/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/merck-serono-completes-enrolment-for-erbitux-gastric-cancer-trial/1278426/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/nci-cancer-bulletin-for-january-11-2011-national-cancer-institute/1278425/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/arch-dermatol-sign-in-page/1278424/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/vivir-con-metastasis-de-cancer-de-mama-no-es-color-de-rosa-tncomar-tod/1278423/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/a-pink-ribbon-race-years-long-heraldtribunecom/1278422/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/agendia-planning-to-file-ipo-in-2011-genomeweb-daily-news-dxpgx-genome/1278421/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/genentech-provides-update-on-fda-application-for-t-dm1-marketwatch/1234943/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/ways-in-which-fingerprints-can-fade-pasadena-star-news/1234942/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/pathological-complete-response-after-neoadjuvant-chemotherapy-with-tra/1234941/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/news-pegylated-liposomal-doxorubicin-may-be-a-first-line-alternative-t/1196685/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/breast-cancer-drug-rejected-by-nice-health-insurance-magazine/1196684/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/arch-neurol-sign-in-page/1158925/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://xeloda.legalview.com/news-articles/triple-regimen-plus-radiation-effective-for-esophageal-cancer-preopera/1158924/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
</urlset>
